达帕格列净治疗心力衰竭、2 型糖尿病和神经病变：DAPA-HF 和 DELIVER 的 Meta 分析。

IF 10.3 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

JACC. Heart failure Pub Date : 2024-11-01 DOI:10.1016/j.jchf.2024.07.017

Jawad H. Butt MD , Li Shen MD, PhD , Silvio E. Inzucchi MD , Kieran F. Docherty MBChB, PhD , Pardeep S. Jhund MBChB, MSc, PhD , Felipe A. Martinez MD , Marc S. Sabatine MD, MPH , Muthiah Vaduganathan MD, MPH , Scott D. Solomon MD , John J.V. McMurray MD , DAPA-HF and DELIVER Committees and Investigators

{"title":"达帕格列净治疗心力衰竭、2 型糖尿病和神经病变：DAPA-HF 和 DELIVER 的 Meta 分析。","authors":"Jawad H. Butt MD , Li Shen MD, PhD , Silvio E. Inzucchi MD , Kieran F. Docherty MBChB, PhD , Pardeep S. Jhund MBChB, MSc, PhD , Felipe A. Martinez MD , Marc S. Sabatine MD, MPH , Muthiah Vaduganathan MD, MPH , Scott D. Solomon MD , John J.V. McMurray MD , DAPA-HF and DELIVER Committees and Investigators","doi":"10.1016/j.jchf.2024.07.017","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":"12 11","pages":"Pages 1946-1948"},"PeriodicalIF":10.3000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Dapagliflozin in Heart Failure, Type 2 Diabetes, and Neuropathy\",\"authors\":\"Jawad H. Butt MD , Li Shen MD, PhD , Silvio E. Inzucchi MD , Kieran F. Docherty MBChB, PhD , Pardeep S. Jhund MBChB, MSc, PhD , Felipe A. Martinez MD , Marc S. Sabatine MD, MPH , Muthiah Vaduganathan MD, MPH , Scott D. Solomon MD , John J.V. McMurray MD , DAPA-HF and DELIVER Committees and Investigators\",\"doi\":\"10.1016/j.jchf.2024.07.017\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":14687,\"journal\":{\"name\":\"JACC. Heart failure\",\"volume\":\"12 11\",\"pages\":\"Pages 1946-1948\"},\"PeriodicalIF\":10.3000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JACC. Heart failure\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2213177924005985\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC. Heart failure","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213177924005985","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Dapagliflozin in Heart Failure, Type 2 Diabetes, and Neuropathy

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

JACC. Heart failure CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

21.20

自引率

2.30%

发文量

164

期刊介绍： JACC: Heart Failure publishes crucial findings on the pathophysiology, diagnosis, treatment, and care of heart failure patients. The goal is to enhance understanding through timely scientific communication on disease, clinical trials, outcomes, and therapeutic advances. The Journal fosters interdisciplinary connections with neuroscience, pulmonary medicine, nephrology, electrophysiology, and surgery related to heart failure. It also covers articles on pharmacogenetics, biomarkers, and metabolomics.